Interleukin-12 in Treating Patients With Cancer in the Abdomen - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Interleukin-12 in Treating Patients With Cancer in the Abdomen

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003046

Locations


United States, Texas
	University of Texas - MD Anderson Cancer Center
	Houston, Texas, United States, 77030-4009

Sponsors and Collaborators

M.D. Anderson Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Renato Lenzi, MD	M.D. Anderson Cancer Center